Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,654Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Kisqali

PharmaCompass

01

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

02

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

03

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

04

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

Brand Name : Kisqali

arrow
iPHEX India
Not Confirmed

Ribociclib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 2,080

2022 Revenue in Millions : 1,231

Growth (%) : 69

blank

05

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

Brand Name : Kisqali

arrow
iPHEX India
Not Confirmed

Ribociclib

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 3,033

2023 Revenue in Millions : 2,080

Growth (%) : 46

blank

06

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

Brand Name : Kisqali

arrow
iPHEX India
Not Confirmed

Ribociclib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 76

2016 Revenue in Millions : 0

Growth (%) : New Launch

blank

07

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed

08

Brand Name : Kisqali

Ribociclib

arrow
iPHEX India
Not Confirmed